Olaf Martin Hoffmann1, Corinna Dinse2, Florian Masuhr2. 1. Klinik für Neurologie, Alexianer St. Josefs-Krankenhaus Potsdam, Allee nach Sanssouci 7, 14471, Potsdam, Deutschland. o.hoffmann@alexianer.de. 2. Klinik für Neurologie, Bundeswehrkrankenhaus Berlin, Berlin, Deutschland.
Abstract
BACKGROUND: In Germany, postmortem organ donation requires a diagnosis of irreversible brain death (BD) in strict compliance with the guidelines of the German Medical Association. OBJECTIVE: Identification of factors that have a limiting effect on the initiation and execution of BD diagnostics. Identification of potential for improvement. MATERIAL AND METHODS: Anonymous survey of transplantation officials in hospitals in Berlin, Brandenburg and Mecklenburg-Western Pomerania. RESULTS: There is considerable heterogeneity with respect to the frequency of BD diagnostics and hospital-specific procedures, including the use of an existing consultation service. The local availability of qualified doctors and of suitable ancillary diagnostic tests has a structurally limiting effect. This is especially true for pediatric patients. Potential for improvement was seen in the identification of affected patients, the motivation of staff and the role of transplantation officials. CONCLUSION: According to the recently amended German Transplantation Act, a centrally organized consultation service for BD diagnostics must be implemented as soon as 2021. Recommendations can be derived from the present survey and from the experience of the regionally established consultation service. In addition to neurological and neurosurgical expertise, qualified pediatricians and mobile ancillary instrumental diagnostics should also be provided. Expert advice from neurointensive care physicians should be available at an early stage in order to identify potentially affected patients. The highly variable participation of hospitals in organ donation, despite the availability of an expert diagnostic service free of charge, points to an important role of additional factors, some of which may be nonmedical in nature.
BACKGROUND: In Germany, postmortem organ donation requires a diagnosis of irreversible brain death (BD) in strict compliance with the guidelines of the German Medical Association. OBJECTIVE: Identification of factors that have a limiting effect on the initiation and execution of BD diagnostics. Identification of potential for improvement. MATERIAL AND METHODS: Anonymous survey of transplantation officials in hospitals in Berlin, Brandenburg and Mecklenburg-Western Pomerania. RESULTS: There is considerable heterogeneity with respect to the frequency of BD diagnostics and hospital-specific procedures, including the use of an existing consultation service. The local availability of qualified doctors and of suitable ancillary diagnostic tests has a structurally limiting effect. This is especially true for pediatric patients. Potential for improvement was seen in the identification of affected patients, the motivation of staff and the role of transplantation officials. CONCLUSION: According to the recently amended German Transplantation Act, a centrally organized consultation service for BD diagnostics must be implemented as soon as 2021. Recommendations can be derived from the present survey and from the experience of the regionally established consultation service. In addition to neurological and neurosurgical expertise, qualified pediatricians and mobile ancillary instrumental diagnostics should also be provided. Expert advice from neurointensive care physicians should be available at an early stage in order to identify potentially affected patients. The highly variable participation of hospitals in organ donation, despite the availability of an expert diagnostic service free of charge, points to an important role of additional factors, some of which may be nonmedical in nature.
Entities:
Keywords:
Consultation service; Guidelines; Irreversible loss of brain function; Neurointensive care; Organ donation
Authors: U Janssens; K M Lücking; B Böll; H Burchardi; K Dannenberg; G Duttge; R Erchinger; P Gretenkort; C Hartog; S Jöbges; K Knochel; M Liebig; S Meier; A Michalsen; G Michels; M Mohr; F Nauck; P Radke; A Rogge; F Salomon; A-H Seidlein; H Stopfkuchen; G Neitzke Journal: Med Klin Intensivmed Notfmed Date: 2019-02 Impact factor: 0.840
Authors: G Neitzke; A Rogge; K M Lücking; B Böll; H Burchardi; K Dannenberg; G Duttge; J Dutzmann; R Erchinger; P Gretenkort; C Hartog; S Jöbges; K Knochel; M Liebig; S Meier; A Michalsen; G Michels; M Mohr; F Nauck; F Salomon; A-H Seidlein; G Söffker; H Stopfkuchen; U Janssens Journal: Med Klin Intensivmed Notfmed Date: 2019-05 Impact factor: 0.840
Authors: D Lustbader; D O'Hara; E F M Wijdicks; L MacLean; W Tajik; A Ying; E Berg; M Goldstein Journal: Neurology Date: 2010-12-15 Impact factor: 9.910
Authors: U Janssens; H Burchardi; G Duttge; R Erchinger; P Gretenkort; M Mohr; F Nauck; S Rothärmel; F Salomon; P Schmucker; A Simon; H Stopfkuchen; A Valentin; N Weiler; G Neitzke Journal: Anaesthesist Date: 2013-01 Impact factor: 1.041
Authors: M Brauer; A Günther; K Pleul; M Götze; C Wachsmuth; T Meinig; M Bauer; O W Witte; A Rahmel Journal: Anaesthesist Date: 2018-11-16 Impact factor: 1.041